ProteinSimple NanoPro 1000
2 December 2015 | By ProteinSimple
Simple Western™ system for the characterization of post-translational protein modification by the detection of charge isoforms...
List view / Grid view
2 December 2015 | By ProteinSimple
Simple Western™ system for the characterization of post-translational protein modification by the detection of charge isoforms...
30 November 2015 | By Victoria White
Heptares and Pfizer have announced they are to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas...
30 November 2015 | By Victoria White
The aim of the project is to design a drug to inhibit a key parasite enzyme involved in the conversion of blood sugars to energy, to be effective in small doses, even on advanced infections, and kill the parasite...
27 November 2015 | By Victoria White
Researchers have discovered how connections between brain cells are destroyed in the early stages of Alzheimer’s disease...
27 November 2015 | By
Pelago and AstraZeneca will together develop assay formats and applications of the CETSA method relevant across the range of AstraZeneca’s therapeutic areas...
25 November 2015 | By Victoria White
The transaction, expected to complete next month, is aimed at strengthening ReproCELL’s pharmaceutical industry-targeted drug discovery services...
25 November 2015 | By
Ablynx and Novo Nordisk hope to discover and develop novel multi-specific drug candidates using Ablynx's proprietary Nanobody technology...
22 November 2015 | By Illumina
In this webinar, we focus on the use of microarray technology in drug development...
20 November 2015 | By Victoria White
The company has announced three new partnerships that will deliver a collaborative screening platform, space-age robotics, and sound waves that can move liquids...
16 November 2015 | By Victoria White
Researchers have created molecules that mimic and dominate toxic ones secreted by bacteria. The implications for the study of biology and pharmacology are said to be enormous...
11 November 2015 | By Victoria White
Of the total investment, EUR 5 billion will go to preclinical R&D with EUR 1.5 billion thereof planned for collaborations with external partners...
10 November 2015 | By Victoria White
The initiative aims to accelerate research into biology's "invisible mass" to provide novel insights into cell function and a new frontier in drug discovery...
4 November 2015 | By Victoria White
IPC will perform chemo-informatic virtual screening of a pre-selected Eisai chemical library, to identify new protein-protein inhibitors for further biological evaluation...
3 November 2015 | By Victoria White
The aim of the collaboration is to deliver potential first-in-class small molecules as lead candidate drugs for multiple oncology indications...
29 October 2015 | By Victoria White
Domainex is expanding all aspects of its drug discovery service business including biology, analytical chemistry and medicinal chemistry...